Apyx Medical Inc Cash Flow Conversion Efficiency
Apyx Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Apyx Medical Inc (APYX) has a cash flow conversion efficiency ratio of -0.315x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.49 Million) by net assets ($11.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Apyx Medical Inc (1995–2025)
Cash flow conversion efficiency of Apyx Medical Inc from 1995 to 2025. This chart illustrates how Apyx Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Apyx Medical Inc for real-time trading data and today's change.
Apyx Medical Inc Cash Flow Conversion Ratio Explained
Apyx Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Apyx Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apyx Medical Inc ranked by their cash flow conversion efficiency. Also see APYX market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sam Young Chem
KO:003720
|
0.149x |
|
Hung -Gu Oil Ltd
KQ:024060
|
0.020x |
|
Nkarta Inc
NASDAQ:NKTX
|
-0.098x |
|
WCT Holdings Bhd
KLSE:9679
|
-0.027x |
|
MTM Critical Metals Ltd
AU:MTM
|
-0.097x |
|
Besiktas Futbol Yatirimlari Sanayi ve Ticaret AS
IS:BJKAS
|
0.286x |
|
Minerva Neurosciences Inc
NASDAQ:NERV
|
21.365x |
|
Humanica Public Company Limited
BK:HUMAN
|
0.044x |
Annual Cash Flow Conversion Efficiency for Apyx Medical Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Apyx Medical Inc from 1995 to 2025. Review APYX FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $14.83 Million | $-8.00 Million | -0.539x | +57.15% |
| 2024-12-31 | $14.34 Million | $-18.05 Million | -1.259x | -545.71% |
| 2023-12-31 | $26.92 Million | $-5.25 Million | -0.195x | +63.67% |
| 2022-12-31 | $37.79 Million | $-20.28 Million | -0.537x | -177.36% |
| 2021-12-31 | $54.01 Million | $-10.45 Million | -0.193x | +23.10% |
| 2020-12-31 | $63.86 Million | $-16.07 Million | -0.252x | +2.96% |
| 2019-12-31 | $71.26 Million | $-18.48 Million | -0.259x | -8.30% |
| 2018-12-31 | $87.77 Million | $-21.01 Million | -0.239x | -42.39% |
| 2017-12-31 | $22.03 Million | $-3.70 Million | -0.168x | -55.40% |
| 2016-12-31 | $26.22 Million | $-2.84 Million | -0.108x | +56.24% |
| 2015-12-31 | $23.40 Million | $-5.79 Million | -0.247x | -178.29% |
| 2014-12-31 | $4.69 Million | $-417.00K | -0.089x | +25.28% |
| 2013-12-31 | $21.33 Million | $-2.54 Million | -0.119x | -1749.74% |
| 2012-12-31 | $22.89 Million | $165.00K | 0.007x | -91.60% |
| 2011-12-31 | $22.12 Million | $1.90 Million | 0.086x | +429.82% |
| 2010-12-31 | $21.77 Million | $-566.00K | -0.026x | -459.43% |
| 2009-12-31 | $21.15 Million | $-98.33K | -0.005x | -111.76% |
| 2008-12-31 | $18.79 Million | $742.83K | 0.040x | -67.48% |
| 2007-12-31 | $16.79 Million | $2.04 Million | 0.122x | -42.27% |
| 2006-12-31 | $14.18 Million | $2.99 Million | 0.211x | +1204.09% |
| 2005-12-31 | $9.94 Million | $-189.62K | -0.019x | -108.64% |
| 2004-12-31 | $9.26 Million | $2.04 Million | 0.221x | +297.81% |
| 2003-12-31 | $7.45 Million | $413.52K | 0.056x | +387.04% |
| 2002-12-31 | $6.49 Million | $73.98K | 0.011x | -91.52% |
| 2001-12-31 | $7.00 Million | $940.78K | 0.134x | +30.68% |
| 2000-12-31 | $6.39 Million | $657.50K | 0.103x | +16.53% |
| 1999-12-31 | $6.01 Million | $530.72K | 0.088x | +5950.81% |
| 1998-12-31 | $9.29 Million | $-14.01K | -0.002x | +96.60% |
| 1997-12-31 | $2.22 Million | $-98.79K | -0.044x | -121.09% |
| 1996-12-31 | $2.02 Million | $425.30K | 0.211x | +594.39% |
| 1995-12-31 | $412.30K | $12.50K | 0.030x | -- |
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more